Immunotherapy Cost
Your health, our priority – We offer you the finest treatment with personalized care that goes beyond treatment. Reach out to us today.
Immunotherapy is revolutionizing cancer treatment by empowering the body’s immune system to recognize and destroy cancer cells. For many advanced or resistant cancers—including lung, bladder, melanoma, kidney, lymphoma, and leukemia—immunotherapy offers not just extended survival, but sometimes lasting remission.
India has emerged as a destination of choice—offering globally recognized immunotherapies at a fraction of Western prices, supported by top-tier hospitals and leading oncologists. This comprehensive guide covers everything you need to know about immunotherapy costs, therapy types, success rates, and why patients from around the world choose India for treatment.
Understanding Immunotherapy and Its Variants
Immunotherapy refers to a range of treatments that boost or guide the immune system to target cancer cells effectively. Major classes include:
- Checkpoint inhibitors (e.g. nivolumab, pembrolizumab, atezolizumab)
- Monoclonal antibodies targeting tumor-specific antigens
- CAR T‑cell therapy (engineered T‑cells directed at cancer targets)
- Cancer vaccines designed to stimulate immune response
- Cytokines and immunomodulators that enhance immune activity
- Adoptive cell transfer and other personalized cell therapies
India now offers all of these modalities, often under expert care and at significantly lower costs compared to western countries.
How Immunotherapy Works
These therapies work by:
- Blocking tumor-mediated immune suppression (via PD‑1/PD‑L1 or CTLA‑4 pathways)
- Genetically reprogramming a patient’s T-cells to attack cancer
- Enhancing immune cell proliferation or function with cytokines or drugs
- Training the body to recognize cancer-specific antigens
Such treatments can lead to durable responses—even in metastatic disease—especially when guided by biomarkers like PD-L1 expression or mismatch repair status.
Why Choose India for Cancer Immunotherapy
- Substantial cost advantage over Western countries
- Modern treatment protocols and global-standard care
- Shorter waiting times, especially for urgent or advanced cases
- Multilingual support and medical tourism facilitators for international patients
- High-quality clinical infrastructure–PET-CT, in‑house labs, molecular diagnostics, clinical trial access
- Compassionate care models, especially in public institutions with subsidized pricing
Planning Your Immunotherapy Journey
Pre-treatment Requirements:
- Biopsy confirmation and genomic profiling (e.g. PD-L1, TMB, MSI)
- PET‑CT/MRI/CT scans to stage disease
- Baseline blood tests and organ function evaluation
- Second opinion if needed
Treatment Scheduling:
- Most immunotherapy drugs are administered via IV infusion in daycare/OPD settings
- Patients need medical footing for side-effect monitoring
- Session frequency varies: weekly, every 2-week, monthly depending on drug
Monitoring & Follow‑Up:
- Periodic imaging (CT, PET) to assess response
- Regular blood tests to monitor organ function and immune-related effects
- Allergy or immune‑mediated adverse events managed through dexamethasone, antihistamines
Emotional & Financial Preparation:
- Emotional counseling and support for side effects or uncertainty
- Financial counseling to plan cycles, drug availability, and subsidies
- Engage with patient support groups or hospital social workers
Conclusion
Immunotherapy represents a transformative advancement in cancer treatment offering durable responses with fewer side effects. India delivers this cutting-edge care at significantly lower costs—with access to CAR‑T therapies, checkpoint inhibitors, vaccines, and personalized cell therapies. Top hospitals, global-quality diagnostics, and compassionate care models combine to make India a compelling choice for international patients seeking world-class cancer care on a budget.
India offers not just affordable pricing, but also state-of-the-art protocols, clinical trial access, and continuous patient support. Whether you’re exploring options in checkpoint therapy or advanced CAR‑T cell treatment, India provides therapeutic hope, emerging success, and a healing environment.
Top Hospitals for Immunotherapy Cost
Below are the list of the top hospitals that are known for Immunotherapy Cost procedures:
Apollo Hospitals Jubilee Hills Hyderabad
Established in: 1988
Number of Beds: 550+
Multi Specialty
Location: Hyderabad
Jaypee Hospital, Noida
Established in: 2014
Number of Beds: 525+
Multi Specialty
Location: Noida
Apollo Excelcare, Guwahati
Established in: 2017
Number of Beds: 550 Beds
Multi Specialty Hospital
Location: Guwahati, Assam
Apollo Hospitals, Hyderguda
Established in: 1988
Number of Beds: 100+ Beds
Multi Specialty Hospital
Location: Hyderguda, Hyderabad, Telangana
Medanta Super Speciality Hospital, Indore
Established in: 2014
Number of Beds: 175 Beds
Multi Specialty Hospital
Location: Indore, Madhya Pradesh
Care Hospitals, Banjara Hills, Hyderabad
Established in: 2000
Number of Beds: 435
Multi Specialty
Location: Hyderabad
Venkateshwar Dwarka, Delhi
Established in: 2016
Number of Beds: 325
Multi-Specialty Hospital
Location: New Delhi
Fortis Escorts Hospital, Jaipur
Established in: 2008
Number of Beds: 275
Multi Specialty Hospital
Location: Malviya Nagar, Jaipur, Rajasthan, India
Max Super Speciality Hospital, Patparganj
Established in: 1993
Number of Beds: 402 Beds
Multi Specialty Hospital
Location: Patparganj (I.P. Extension), East Delhi, Delhi, India
Fortis C-DOC Hospital, Chirag Enclave
Established in: 2012
Number of Beds: 23 Beds
Multi Specialty Hospital
Location: Chirag Enclave, Greater Kailash, New Delhi
Our Services
Transparent • Professional • Without Hassles
Compare Cost Estimates
Get detailed cost breakdowns and compare prices across multiple hospitals
Book Doctor Appointment
Schedule appointments with top specialists at your convenience
Hospitalisation Support
Complete assistance from admission to discharge with dedicated care
Video Consultation
Consult doctors online or in-person based on your preference
Travel Assistance
Visa support, flight booking, and airport pickup services
Language Interpreter
Multilingual support to ensure clear communication
Accommodation
Comfortable stay arrangements near the hospital
24/7 Support
Round-the-clock assistance for all your medical needs
Top Immunotherapy Cost Specialists
Dr. Priya Tiwari
Gurugram4.0
Experience: 19+
Education: MBBS , MD , DM
Get a free consultancy
Dr. Piyush Kumar Agarwal
Gurugram4.0
Experience: 20
Education: MBBS, MS, M.Ch
Get a free consultancy
Prof. Dr. Suleyman Alici
Istanbul, Turkey4.0
Experience: 35
Education:
Get a free consultancy
Dr. Vivek Gupta
Saket, India4.0
Experience: 27
Education: MBBS, MS, DNB
Get a free consultancy
Dr. Prof Suresh H Advani
Mumbai4.0
Experience: 55+
Education: MBBS, MD, Fellowship
Get a free consultancy
Dr. Kapil Kumar
Delhi4.0
Experience: 45
Education: BBS, MS, FICS
Get a free consultancy
Dr. Nagendra Prasad Tripathy
Bengaluru, Karnataka, India4.0
Experience: 20+ Years of experience
Education: MBBS, MS (General Surgery), and M.Ch
Get a free consultancy
Dr. Debashish Chaudhary
Delhi4.0
Experience: 25
Education: MBBS , MS, MCh
Get a free consultancy
Dr. Tapan Singh Chauhan
Gurugram4.0
Experience: 18+
Education: MBBS, MS, MCh, Fellowship, MRCS
Get a free consultancy
Get Free Consultation
Fill out the form below and our team will get back to you shortly
Treatment Costs in India
Factors Influencing Cost in India
Treatment costs in India vary depending on several major factors:
- Type of immunotherapy drug (e.g. checkpoint inhibitor vs CAR‑T cell)
- Brand name vs biosimilar or Indian generic
- Frequency and total number of cycles
- Cancer type and stage (solid tumor vs hematologic malignancy)
- Diagnostic tests and biomarker profiling (e.g. PD‑L1, MSI, TMB)
- Hospital choice (private multispecialty, government institute, JCI/NABH accreditation)
- City or region (metro cities may charge more)
- Supportive medications, imaging, follow-up care
- Daycare vs inpatient setting depending on complications
How Much Does Immunotherapy Cost in India?
Single-Cycle Cost Estimates
Per cycle cost range in India:
- Checkpoint inhibitors: ₹80,000 – ₹150,000 (approx. $1,000–2,000)
- Monoclonal antibodies / targeted antibodies: ₹150,000 – ₹400,000
- Cancer vaccines or cytokines: ₹50,000 – ₹200,000
- Adoptive cell therapy (non‑CAR‑T): ₹300,000 – ₹700,000
- CAR T‑cell therapy (e.g. NexCAR19 in India): ₹30,00,000 – ₹60,00,000+
- Immunomodulators: ₹100,000 – ₹300,000 per cycle
Full Treatment Course (Multi-cycle)
Patients often require 4 to 12 cycles, depending on response and protocol. Total cost for a full course:
- Lower-end immunotherapy courses: ₹3,00,000 – ₹8,00,000
- Comprehensive checkpoint regimens (e.g., pembrolizumab/nivolumab): ₹10,00,000 – ₹45,00,000
CAR‑T Cell therapy course: ₹30,00,000 – ₹60,00,000+ depending on hospital and consumables
Breaking Down Additional Costs
Aside from drug charges, other expenses include:
- Consultation & oncology evaluations: ₹500 – ₹5,000 per visit
- Pre‑treatment scans (PET‑CT, MRI, CT): ₹5,000 – ₹40,000
- Diagnostic biopsy and blood tests: ₹1,000 – ₹30,000
- PD‑L1, MSI, TMB and genomic profiling: Usually ₹20,000–50,000+
- Support medications (steroids, anti-inflammatories): Variable, depending on side‑effects
- Daycare facility charges or brief hospitalization
Even factoring these in, the total cost is typically far lower than Western countries.
Frequently Asked Questions
FAQs
- Who is eligible for immunotherapy?
Patients with advanced or refractory cancers where targetable biomarkers (PD-L1, MSI, etc.) are positive; defined cancer types (melanoma, lung, bladder, lymphoma). - What is the typical success rate?
Approximately 15–20% of patients achieve durable remission with checkpoint inhibitors; CAR T-cell therapy offers higher remission in eligible blood cancers (> 50% long-term in many centers) - Are generics or biosimilars available?
Some biosimilars of pembrolizumab or nivolumab are being developed locally, offering reduced cost—though many hospitals still use branded drugs. - Can insurance cover immunotherapy?
Increasingly yes; national schemes and private insurers cover drugs if approved. Pharma patient‑support programs also assist. Check your policy details. - What are common side effects?
Mild flu-like symptoms, fatigue, rashes, organ inflammation (colitis, pneumonitis), endocrine dysfunction, blood count changes. - Can international patients access treatment easily?
Yes—major hospitals offer medical visa support, transport coordination, interpreter services, and personalized case managers. - Is CAR T‑cell therapy available in India?
Yes. Institutions like Tata Memorial and private hospitals offer CAR‑T therapy like NexCAR19 at ₹30–40 lakh, much lower than international cost (~₹3–4 crore). - Are there affordable options for low-income patients?
Yes—government hospitals and charitable centres (Kidwai, Tata Memorial, RCC Thiruvananthapuram) offer subsidized or free treatment.
9. Are there any side effects of immunotherapy?
Yes, while immunotherapy is generally well-tolerated compared to chemotherapy, some patients may experience side effects such as:
- Fatigue
- Skin rash or itching
- Flu-like symptoms
- Inflammation in organs (lungs, liver, or intestines)
- Autoimmune reactions in rare cases
These side effects are usually manageable with medications or by adjusting the therapy.
10. How long does immunotherapy treatment last in India?
The duration of immunotherapy varies depending on your cancer type, treatment response, and tolerance. In many cases, treatment is given every 2 to 3 weeks over a course of 6 months to 2 years. Some patients may require long-term maintenance therapy if they continue to respond well.
11. Can international patients get immunotherapy treatment in India?
Absolutely. India is a leading medical tourism destination for cancer care, including immunotherapy. Top hospitals in cities like Delhi, Mumbai, Chennai, and Bengaluru offer world-class immunotherapy protocols at much lower costs compared to the US, UK, or Europe. International patients are provided with visa support, airport pick-up, multilingual coordinators, and post-treatment care assistance.